415-389-4670655 Redwood Highway #395, Mill Valley, California 94941
TwitterFacebookLinkedin
Liviakis Financial Communications Inc.Liviakis Financial Communications Inc.
Liviakis Financial Communications Inc.
Comprehensive Investor Relations Services in partnership with growth companies
  • HOME
  • ABOUT LIVIAKIS
  • SERVICES
  • CORPORATE PORTFOLIO
  • NEWS
    • COMPANY NEWS
    • OUR BLOG
  • CONTACT
Menu back  
COMPANY NEWS
Date Name
DescAsc

Wealth Initiates New Geophysical Survey in Atacama Region

GlobeNewswire•September 17, 2018 VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQB: WMLLF; SSE: WMLCL; Frankfurt: EJZN), announces that following up on positive Transient Electromagnetic (“TEM”) and Magnetic Telluric (“MT”) geophysical survey results (see news release December 14, 2017), at the Company’s Atacama Project…

Details
September 17, 2018

Energy Fuels Repays and Retires Wyoming Debt

LAKEWOOD, CO , Sept. 12, 2018 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States , is pleased to announce that it has repaid and retired the entire outstanding principal balance of its Wyoming Industrial Development Revenue Bond…

Details
September 12, 2018

CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement

GlobeNewswire•September 5, 2018 LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year licensing agreement for the first time with a leading international cannabis company. Under the terms of the agreement, the cannabis company will have an exclusive…

Details
September 5, 2018

Energy Fuels Significantly Strengthens Uranium Position in Wyoming through Acquisition of Royalties; Provides State with Notice of Intent to Repay Debt

LAKEWOOD, CO , Aug. 14, 2018 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States , is pleased to announce that it has completed the previously announced acquisition from Excalibur Industries (“Excalibur”) of royalties on the Company’s 100%-owned…

Details
August 15, 2018

Laguna Verde Update

GlobeNewswire•July 31, 2018 VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (WML.V) (WMLLF) (SSE:WMLCL) (EJZN.F), announces an operational update for the Laguna Verde Project (the “Project” or “Laguna Verde”). Preliminary Economic Assessment Wealth has commissioned several industry-leading consultants and advisors to produce a Preliminary Economic Assessment…

Details
July 31, 2018

Atacama Project Update

GlobeNewswire•July 25, 2018 VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (WML.V) (WMLLF) (SSE:WMLCL) (EJZN.F), announces delays in its Atacama Project (the “Project”) drilling program. The Company mobilized and transported a sonic drill rig to the Project area this week, at which time local community representatives…

Details
July 25, 2018

Ur-Energy and Energy Fuels Announce U.S. Department of Commerce Has Initiated Investigation into Effects of Uranium Imports on U.S. National Security

DENVER, July 18, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels”) and Ur-Energy Inc. (NYSE American: URG; TSX: URE) (“Ur-Energy”) are pleased to announce that on July 18, 2018, the U.S. Department of Commerce (“DOC”) initiated an investigation into the effects of uranium imports on U.S. national security. This investigation was…

Details
July 18, 2018

Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

Oxnard, CA – July xx, 2018 – CURE Pharmaceutical (OTCQB: CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix Biosciences Ltd. (Nasdaq: TRPX), (“Therapix”), a specialty, clinical-stage pharmaceutical company developing cannabinoid-based treatments, to acquire the non-pain assets of Therapix, subject to the completion of…

Details
July 11, 2018
1
23
…45678…
9
10
Prev pageNext page
COMPANY & BLOG UPDATES
RECENT NEWS
  • Wealth Minerals to Present at the LD Micro Main Event (XII) December 6, 2019
  • CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference December 5, 2019
  • CURE Pharmaceutical Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors November 19, 2019
  • CURE Pharmaceutical Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension November 14, 2019
  • Wealth Minerals Provides Corporate Update November 12, 2019
CONTACT US
Phone: 415-389-4670
Fax: 415-389-4694
655 Redwood Highway #395
 Mill Valley, California 94941

Our privacy policy
COMPANY NEWS
  • Wealth Minerals to Present at the LD Micro Main Event (XII)
    December 6, 2019
  • CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference
    December 5, 2019
ABOUT LIVIAKIS
  • Testimonials
  • Press
  • Philanthropy
SITEMAP
  • About Liviakis
  • Services
  • Corporate Portfolio
  • Company News
  • Contact
Liviakis Financial Communications Inc.
©2015 Liviakis Financial | All Rights Reserved

Website Design: Hi 5 Studio | Video Production: Mav Media